XML 27 R112.htm IDEA: XBRL DOCUMENT v2.4.0.6
Subsidiary Guarantor Information for Koppers Inc. Senior Notes and Shelf Registration - Condensed Consolidating Statement of Cash Flows (Detail) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Subsidiary, Sale of Stock [Line Items]      
Cash provided by (used in) operating activities $ 77.8 $ 76.9 $ 105.3
Cash provided by (used in) investing activities:      
Capital expenditures and acquisitions (28.9) (33.2) (29.9)
Loan to related party 2.2 (11.7) 0
Net cash proceeds (payments) from divestitures and asset sales 0.8 0.8 2.0
Net cash provided by (used in) investing activities (39.9) (44.7) (63.4)
Cash provided by (used in) financing activities:      
Deferred financing costs (0.1) (0.5) (0.4)
Dividends paid (19.5) (18.2) (23.1)
Stock repurchased (8.1) (0.3) (0.9)
Net cash used in financing activities (27.3) (13.3) (64.3)
Effect of exchange rates on cash 2.0 (0.1) (0.7)
Net decrease in cash and cash equivalents 12.6 18.8 (23.1)
Cash and cash equivalents at beginning of year 54.1 35.3 58.4
Cash and cash equivalents at end of year 66.7 54.1 35.3
Senior Notes [Member]
     
Subsidiary, Sale of Stock [Line Items]      
Cash provided by (used in) operating activities 77.8 76.9 105.3
Cash provided by (used in) investing activities:      
Capital expenditures and acquisitions (42.9) (33.8) (65.4)
Loan to related party 2.2 (11.7)  
Net cash proceeds (payments) from divestitures and asset sales 0.8 0.8 2.0
Net cash provided by (used in) investing activities (39.9) (44.7) (63.4)
Cash provided by (used in) financing activities:      
Borrowings (repayments) of long-term debt (6.4) 5.4 (40.2)
Deferred financing costs (0.1) (0.5) (0.4)
Dividends paid (19.5) (18.2) (23.1)
Stock repurchased (6.6)    
Stock issued (repurchased)     (0.6)
Other financing receipts 5.3    
Net cash used in financing activities (27.3) (13.3) (64.3)
Effect of exchange rates on cash 2.0 (0.1) (0.7)
Net decrease in cash and cash equivalents 12.6 18.8 (23.1)
Cash and cash equivalents at beginning of year 54.1 35.3 58.4
Cash and cash equivalents at end of year 66.7 54.1 35.3
Shelf Registration [Member]
     
Subsidiary, Sale of Stock [Line Items]      
Cash provided by (used in) operating activities 77.8 76.9 105.3
Cash provided by (used in) investing activities:      
Capital expenditures and acquisitions (42.9) (33.8) (65.4)
Loan to related party 2.2 (11.7)  
Net cash proceeds (payments) from divestitures and asset sales 0.8 0.8 2.0
Net cash provided by (used in) investing activities (39.9) (44.7) (63.4)
Cash provided by (used in) financing activities:      
Borrowings (repayments) of long-term debt (6.4) 5.4 (40.2)
Deferred financing costs (0.1) (0.5) (0.4)
Dividends paid (19.5) (18.2) (23.1)
Stock issued (repurchased) (6.6)   (0.6)
Other financing receipts 5.3    
Net cash used in financing activities (27.3) (13.3) (64.3)
Effect of exchange rates on cash 2.0 (0.1) (0.7)
Net decrease in cash and cash equivalents 12.6 18.8 (23.1)
Cash and cash equivalents at beginning of year 54.1 35.3 58.4
Cash and cash equivalents at end of year 66.7 54.1 35.3
Parent [Member] | Senior Notes [Member]
     
Subsidiary, Sale of Stock [Line Items]      
Cash provided by (used in) operating activities 26.0 18.1 18.7
Cash provided by (used in) investing activities:      
Capital expenditures and acquisitions 0 0 0
Loan to related party 0 0  
Net cash proceeds (payments) from divestitures and asset sales 0 0 0
Net cash provided by (used in) investing activities 0 0 0
Cash provided by (used in) financing activities:      
Borrowings (repayments) of long-term debt 0 0 0
Deferred financing costs 0 0 0
Dividends paid (19.5) (18.1) (18.1)
Stock repurchased (6.5)    
Stock issued (repurchased)     (0.8)
Other financing receipts 0    
Net cash used in financing activities (26.0) (18.1) (18.9)
Effect of exchange rates on cash 0 0 0
Net decrease in cash and cash equivalents 0 0 (0.2)
Cash and cash equivalents at beginning of year 0 0 0.2
Cash and cash equivalents at end of year 0 0 0
Parent [Member] | Shelf Registration [Member]
     
Subsidiary, Sale of Stock [Line Items]      
Cash provided by (used in) operating activities 26.0 18.1 18.7
Cash provided by (used in) investing activities:      
Capital expenditures and acquisitions 0 0 0
Loan to related party 0 0  
Net cash proceeds (payments) from divestitures and asset sales 0 0 0
Net cash provided by (used in) investing activities 0 0 0
Cash provided by (used in) financing activities:      
Borrowings (repayments) of long-term debt 0 0 0
Deferred financing costs 0 0 0
Dividends paid (19.5) (18.1) (18.1)
Stock issued (repurchased) (6.5)   (0.8)
Other financing receipts 0    
Net cash used in financing activities (26.0) (18.1) (18.9)
Effect of exchange rates on cash 0 0 0
Net decrease in cash and cash equivalents 0 0 (0.2)
Cash and cash equivalents at beginning of year 0 0 0.2
Cash and cash equivalents at end of year 0 0 0
Koppers Inc. [Member] | Senior Notes [Member]
     
Subsidiary, Sale of Stock [Line Items]      
Cash provided by (used in) operating activities 50.5 9.5 75.2
Cash provided by (used in) investing activities:      
Capital expenditures and acquisitions (21.3) (24.5) (35.0)
Loan to related party 0 0  
Net cash proceeds (payments) from divestitures and asset sales 0.4 0.7 0.2
Net cash provided by (used in) investing activities (20.9) (23.8) (34.8)
Cash provided by (used in) financing activities:      
Borrowings (repayments) of long-term debt (6.4) 6.3 (40.2)
Deferred financing costs (0.1) (0.5) (0.4)
Dividends paid (19.8) 0 (4.5)
Stock repurchased (0.1)    
Stock issued (repurchased)     0.2
Other financing receipts 1.6    
Net cash used in financing activities (24.8) 5.8 (44.9)
Effect of exchange rates on cash 0 0.1 0
Net decrease in cash and cash equivalents 4.8 (8.4) (4.5)
Cash and cash equivalents at beginning of year 0 8.4 12.9
Cash and cash equivalents at end of year 4.8 0 8.4
Koppers Inc. [Member] | Shelf Registration [Member]
     
Subsidiary, Sale of Stock [Line Items]      
Cash provided by (used in) operating activities 50.5 9.5 75.2
Cash provided by (used in) investing activities:      
Capital expenditures and acquisitions (21.3) (24.5) (35.0)
Loan to related party 0 0  
Net cash proceeds (payments) from divestitures and asset sales 0.4 0.7 0.2
Net cash provided by (used in) investing activities (20.9) (23.8) (34.8)
Cash provided by (used in) financing activities:      
Borrowings (repayments) of long-term debt (6.4) 6.3 (40.2)
Deferred financing costs (0.1) (0.5) (0.4)
Dividends paid (19.8) 0 (4.5)
Stock issued (repurchased) (0.1)   0.2
Other financing receipts 1.6    
Net cash used in financing activities (24.8) 5.8 (44.9)
Effect of exchange rates on cash 0 0.1 0
Net decrease in cash and cash equivalents 4.8 (8.4) (4.5)
Cash and cash equivalents at beginning of year 0 8.4 12.9
Cash and cash equivalents at end of year 4.8 0 8.4
Domestic Guarantor Subsidiaries [Member] | Senior Notes [Member]
     
Subsidiary, Sale of Stock [Line Items]      
Cash provided by (used in) operating activities 0 0 0
Cash provided by (used in) investing activities:      
Capital expenditures and acquisitions 0 0 0
Loan to related party 0 0  
Net cash proceeds (payments) from divestitures and asset sales 0 0 0
Net cash provided by (used in) investing activities 0 0 0
Cash provided by (used in) financing activities:      
Borrowings (repayments) of long-term debt 0 0 0
Deferred financing costs 0 0 0
Dividends paid 0 0 0
Stock repurchased 0    
Stock issued (repurchased)     0
Other financing receipts 0    
Net cash used in financing activities 0 0 0
Effect of exchange rates on cash 0 0 0
Net decrease in cash and cash equivalents 0 0 0
Cash and cash equivalents at beginning of year 0 0 0
Cash and cash equivalents at end of year 0 0 0
Domestic Guarantor Subsidiaries [Member] | Shelf Registration [Member]
     
Subsidiary, Sale of Stock [Line Items]      
Cash provided by (used in) operating activities 0 0 0
Cash provided by (used in) investing activities:      
Capital expenditures and acquisitions 0 0 0
Loan to related party 0 0  
Net cash proceeds (payments) from divestitures and asset sales 0 0 0
Net cash provided by (used in) investing activities 0 0 0
Cash provided by (used in) financing activities:      
Borrowings (repayments) of long-term debt 0 0 0
Deferred financing costs 0 0 0
Dividends paid 0 0 0
Stock issued (repurchased) 0   0
Other financing receipts 0    
Net cash used in financing activities 0 0 0
Effect of exchange rates on cash 0 0 0
Net decrease in cash and cash equivalents 0 0 0
Cash and cash equivalents at beginning of year 0 0 0
Cash and cash equivalents at end of year 0 0 0
Non-Guarantor Subsidiaries [Member] | Senior Notes [Member]
     
Subsidiary, Sale of Stock [Line Items]      
Cash provided by (used in) operating activities 21.1 49.3 15.9
Cash provided by (used in) investing activities:      
Capital expenditures and acquisitions (21.6) (9.3) (30.4)
Loan to related party 2.2 (11.7)  
Net cash proceeds (payments) from divestitures and asset sales 0.4 0.1 1.8
Net cash provided by (used in) investing activities (19.0) (20.9) (28.6)
Cash provided by (used in) financing activities:      
Borrowings (repayments) of long-term debt 0 (0.9) 0
Deferred financing costs 0 0 0
Dividends paid 0 (0.1) (5.0)
Stock repurchased 0    
Stock issued (repurchased)     0
Other financing receipts 3.7    
Net cash used in financing activities 3.7 (1.0) (5.0)
Effect of exchange rates on cash 2.0 (0.2) (0.7)
Net decrease in cash and cash equivalents 7.8 27.2 (18.4)
Cash and cash equivalents at beginning of year 54.1 26.9 45.3
Cash and cash equivalents at end of year 61.9 54.1 26.9
Non-Guarantor Subsidiaries [Member] | Shelf Registration [Member]
     
Subsidiary, Sale of Stock [Line Items]      
Cash provided by (used in) operating activities 6.9 11.4 6.8
Cash provided by (used in) investing activities:      
Capital expenditures and acquisitions (0.5) (0.7) (0.4)
Loan to related party 2.2 (11.7)  
Net cash proceeds (payments) from divestitures and asset sales 0 0 0.1
Net cash provided by (used in) investing activities 1.7 (12.4) (0.3)
Cash provided by (used in) financing activities:      
Borrowings (repayments) of long-term debt 0 0 0
Deferred financing costs 0 0 0
Dividends paid 0 (0.1) (5.0)
Stock issued (repurchased) 0   0
Other financing receipts 3.7    
Net cash used in financing activities 3.7 (0.1) (5.0)
Effect of exchange rates on cash (0.1) 0.2 0
Net decrease in cash and cash equivalents 12.2 (0.9) 1.5
Cash and cash equivalents at beginning of year 9.0 9.9 8.4
Cash and cash equivalents at end of year 21.2 9.0 9.9
Consolidating Adjustments [Member] | Senior Notes [Member]
     
Subsidiary, Sale of Stock [Line Items]      
Cash provided by (used in) operating activities (19.8) 0 (4.5)
Cash provided by (used in) investing activities:      
Capital expenditures and acquisitions 0 0 0
Loan to related party 0 0  
Net cash proceeds (payments) from divestitures and asset sales 0 0 0
Net cash provided by (used in) investing activities 0 0 0
Cash provided by (used in) financing activities:      
Borrowings (repayments) of long-term debt 0 0 0
Deferred financing costs 0 0 0
Dividends paid 19.8 0 4.5
Stock repurchased 0    
Stock issued (repurchased)     0
Other financing receipts 0    
Net cash used in financing activities 19.8 0 4.5
Effect of exchange rates on cash 0 0 0
Net decrease in cash and cash equivalents 0 0 0
Cash and cash equivalents at beginning of year 0 0 0
Cash and cash equivalents at end of year 0 0 0
Consolidating Adjustments [Member] | Shelf Registration [Member]
     
Subsidiary, Sale of Stock [Line Items]      
Cash provided by (used in) operating activities (19.8) 0 (4.5)
Cash provided by (used in) investing activities:      
Capital expenditures and acquisitions 0 0 0
Loan to related party 0 0  
Net cash proceeds (payments) from divestitures and asset sales 0 0 0
Net cash provided by (used in) investing activities 0 0 0
Cash provided by (used in) financing activities:      
Borrowings (repayments) of long-term debt 0 0 0
Deferred financing costs 0 0 0
Dividends paid 19.8 0 4.5
Stock issued (repurchased) 0   0
Other financing receipts 0    
Net cash used in financing activities 19.8 0 4.5
Effect of exchange rates on cash 0 0 0
Net decrease in cash and cash equivalents 0 0 0
Cash and cash equivalents at beginning of year 0 0 0
Cash and cash equivalents at end of year 0 0 0
Foreign Guarantor Subsidiaries [Member] | Shelf Registration [Member]
     
Subsidiary, Sale of Stock [Line Items]      
Cash provided by (used in) operating activities 14.2 37.9 9.1
Cash provided by (used in) investing activities:      
Capital expenditures and acquisitions (21.1) (8.6) (30.0)
Loan to related party 0 0  
Net cash proceeds (payments) from divestitures and asset sales 0.4 0.1 1.7
Net cash provided by (used in) investing activities (20.7) (8.5) (28.3)
Cash provided by (used in) financing activities:      
Borrowings (repayments) of long-term debt 0 (0.9) 0
Deferred financing costs 0 0 0
Dividends paid 0 0 0
Stock issued (repurchased) 0   0
Other financing receipts 0    
Net cash used in financing activities 0 (0.9) 0
Effect of exchange rates on cash 2.1 (0.4) (0.7)
Net decrease in cash and cash equivalents (4.4) 28.1 (19.9)
Cash and cash equivalents at beginning of year 45.1 17.0 36.9
Cash and cash equivalents at end of year $ 40.7 $ 45.1 $ 17.0